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Abstract
Background: Care for people with advanced dementia requires a palliative approach targeted to the illness trajectory
and tailored to individual needs. However, care in nursing homes is often compromised by poor communication and
limited staff expertise. This paper reports the protocol for the IDEAL Project, which aims to: 1) compare the efficacy of a
facilitated approach to family case conferencing with usual care; 2) provide insights into nursing home- and staff-related
processes influencing the implementation and sustainability of case conferencing; and 3) evaluate cost-effectiveness.
Design/Methods: A pragmatic parallel cluster randomised controlled trial design will be used. Twenty Australian nursing
homes will be randomised to receive either facilitated family case conferencing or usual care.
In the intervention arm, we will train registered nurses at each nursing home to work as Palliative Care Planning
Coordinators (PCPCs) 16 h per week over 18 months. The PCPCs’ role will be to: 1) use evidence-based ‘triggers’
to identify optimal time-points for case conferencing; 2) organise, facilitate and document case conferences with
optimal involvement from family, multi-disciplinary nursing home staff and community health professionals; 3)
develop and oversee implementation of palliative care plans; and 4) train other staff in person-centred palliative care.
The primary endpoint will be symptom management, comfort and satisfaction with care at the end of life as rated by
bereaved family members on the End of Life in Dementia (EOLD) Scales. Secondary outcomes will include resident
quality of life (Quality of Life in Late-stage Dementia [QUALID]), whether a palliative approach is taken (e.g.
hospitalisations, non-palliative medical treatments), staff attitudes and knowledge (Palliative Care for Advanced
Dementia [qPAD]), and cost effectiveness. Processes and factors influencing implementation, outcomes and
sustainability will be explored statistically via analysis of intervention ‘dose’ and qualitatively via semi-structured interviews.
The pragmatic design and complex nature of the intervention will limit blinding and internal validity but support
external validity.
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Discussion: The IDEAL Project will make an important contribution to the evidence base for dementia-specific case
conferencing in nursing homes by considering processes and contextual factors as well as overall efficacy. Its strengths
and weaknesses will both lie in its pragmatic design.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12612001164886. Registered
02/11/2012.
Keywords: End of life care, Palliative care, Dementia, Nursing homes, Person-centred care, Case conferencing,
Advance care planning, Communication, Implementation, Cost effectiveness
Background
Dementia is a chronic, progressive and terminal illness
that requires a palliative approach to care in its advanced
stages [1–3]. Maximising quality of life (QOL) for per-
sons with advanced dementia and their families requires
careful and regular assessment of physical, psychosocial,
cultural and spiritual needs at timely junctures in the ill-
ness trajectory to inform management decision-making
and advance care planning. Symptom assessment and
management must be tailored to the specific needs of
advanced dementia, with an understanding that deterior-
ation is often complicated by comorbid conditions.
Pneumonia and feeding problems are common and re-
quire focused management and planning. People with
advanced dementia have limited capacity to effectively
communicate their needs and participate in decisions
about care, such that symptoms (e.g. pain) often go
under-recognised and under-managed [4–6]. Interven-
tions for acute medical problems (e.g. intravenous anti-
biotics/hydration, tube feeding) should be applied only
at times where they will provide net benefit, rather than
compromise comfort and distress families for little or no
survival benefit [7–13].
Delivery of palliative care to nursing home residents
with advanced dementia is often suboptimal, either
because staff lack awareness that a palliative approach
is required or else find it difficult to apply this to de-
mentia care [2, 4–8, 12, 14–17]. Major barriers in-
clude an inadequate skill-mix, poor communication
between nursing home staff, health services and fam-
ilies, and inadequate planning and/or inconsistency in
decision-making [4, 15]. If an advance care plan is
not in place, staff may be unable or unwilling to
manage symptoms within the nursing home, leading
to unnecessary transfer to hospital [18]. Hospital ad-
missions for people with dementia are more likely to
be lengthy and terminal compared to those for people
without [19]. Hospitalisation is often frightening for resi-
dents and is associated with care focused on acute medical
conditions rather than QOL [20, 21]. Acute care staff may
have limited knowledge about dementia and the person’s
unique needs, and family may have a reduced role in
decision-making [22].
Case conferencing has been promoted as a promising
approach for improving care outcomes for people with
dementia living in nursing homes [23, 24]. It brings to-
gether relevant health professionals and other decision-
makers to discuss healthcare problems with the person
and their family, provides a formal framework to under-
stand expected changes, and can build consensus on
goals of care for advance care planning. For residents
with advanced dementia who cannot speak for them-
selves, case conferences can facilitate the sharing of dif-
ferent perspectives regarding what each resident would
have wanted were (s)he able to choose. The lack of resi-
dent capacity for decision-making mandates involvement
of family members with legal authority to make deci-
sions on behalf of the resident. Moreover, involvement
of family in decision-making may lead to improvements
in their satisfaction with care in and of its own right
[12]. This fits well with the philosophy of a palliative ap-
proach more generally, which assumes that the unit of
care includes family members as well as the person with
life-limiting illness him/herself. However, direct evidence
for a relationship between case conferencing and im-
proved QOL in nursing home residents with dementia is
limited to a cross-sectional survey study [25]. While two
recent systematic reviews [23, 24] identified five rando-
mised controlled trials (RCTs) of case conferencing in
nursing homes [26–30], none were concerned with pal-
liative care or care for residents with advanced dementia.
Moreover, the case conferencing approaches used in
these RCTs did not include family decision-makers, and
only two included health professionals from disciplines
other than nursing [26, 27].
Stronger evidence for an impact from case conferencing
on palliative care quality and outcomes is available in the
community palliative care setting, where two RCTs have
found case conferencing to lead to better maintenance of
physical and mental health [31] and decrease hospitalisa-
tions [32]. The interventions in these studies facilitated
case conferencing via strategies for building staff know-
ledge and motivation to undertake case conferencing, pro-
viding staff with detailed guidance for care planning,
obtaining organisational and administrative support for
case conferencing, and facilitating general practitioner
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attendance [33–35]. The positive results from these trials
highlight the structure and support needed for case con-
ferencing to succeed in the community setting. Support of
this kind may be even more important in the nursing
home setting where staff are sometimes confused about
the purpose of case conferencing and its role in health-
care, uncertain about the need for multidisciplinary input
and the role of different disciplines, and where there is
often a lack of collaborative culture [36, 37].
Aims
The current paper reports the protocol for a cluster
RCT called the IDEAL Project (Implementing Dementia
End of life care At Local aged care facilities). This pro-
ject has been designed to: 1) compare the efficacy of a
facilitated approach to family case conferencing with
usual care with regard to end of life (EOL) care and out-
comes for residents with advanced dementia living in
nursing homes; 2) provide insights into nursing home-
and staff-related processes influencing the implementa-
tion and sustainability of case conferencing; and 3)
evaluate the cost-effectiveness of facilitated family case
conferencing versus usual care.
Hypotheses
Primary hypothesis (Aim 1)
Compared with usual care, facilitated family case confer-
encing for residents with advanced dementia will achieve
better family-rated EOL outcomes as defined by: a) bet-
ter symptom-related comfort in the last 7 days of life; b)
more effective symptom management over the last
90 days of life; c) greater family satisfaction with care
over the last 90 days of the resident’s life.
Hypothesis 2 (Aim 2)
Compared with usual care, facilitated family case confer-
encing for residents with advanced dementia will achieve:
a) improved nurse-rated symptom-related comfort over
the last 7 days of life and symptom management
over the last 90 days of life;
b) higher scores on resident QOL at last measurement
prior to resident death;
c) a palliative approach to medical care of residents
with advanced dementia, as evidenced by reduced
acute care episodes, non-palliative interventions and
adverse incidents at the nursing home level;
d) a person-centred approach by nursing home staff to
all aspects of care;
e) improvements in nursing home staff attitudes to,
knowledge of and confidence in providing palliative
care to residents with advanced dementia and
dementia care more generally.
f ) improvements in family QOL.
Hypothesis 3 (Aim 3)
Compared with usual care, facilitated family case confer-
encing for residents with advanced dementia will result
in EITHER an overall reduction in health care costs with
no loss to resident health OR be cost-effective in terms
of health gained at acceptable additional cost.
Methods
Development of the intervention
The IDEAL Project was informed by the Medical Re-
search Council’s (MRC) framework for complex inter-
ventions [38]. In a development phase, a case
conferencing toolkit was compiled by members of the
team for use in a general nursing home population [39].
During a feasibility and piloting phase, the toolkit and
method of implementation was subjected to preliminary
testing for residents with advanced dementia in six nurs-
ing homes in metropolitan and rural New South Wales
[40]. The pilot demonstrated the acceptability and clin-
ical relevance of the toolkit, dementia-specific “triggers”
for conduct of case conferences based on resident char-
acteristics and/or clinical events (e.g. on admission to
the nursing home, change in clinical status), and a pallia-
tive care framework for mapping the trajectory of resi-
dents in specific domains of disease progression
(functioning, swallowing, weight loss, continence, level
of consciousness, communication, and factors related to
comorbid illness) and identifying issues that case confer-
encing should address. The pilot also informed develop-
ment of a list of competencies for the role of case
conference coordinator and associated training materials
for the nursing home staff, and demonstrated feasibility
of collecting descriptive data and outcome measures in
the evaluation phase. Baseline data collected in the pilot
also confirmed previous findings that, without facilita-
tion, case conferences may seldom occur and/or be of
poor quality [36, 37].
Study design
The IDEAL Project will use a parallel cluster RCT de-
sign because the intervention requires system-level
changes that make it impossible to randomise individual
residents within the same nursing home to different
arms without contamination [41].
We follow previous trials of case conferencing [42] in
taking a pragmatic approach to design with the aim of
improving external validity [43, 44]. Features of prag-
matic trials considered valuable by the project team in-
clude: 1) broad inclusion criteria to reflect the diversity
of nursing homes and residents with advanced dementia
and multiple comorbidities; 2) tailoring of the interven-
tion to local conditions and individual resident needs;
and 3) selection of endpoints focused on clinically im-
portant outcomes. We suggest that these benefits
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outweigh the disadvantages of a pragmatic design,
namely poorer internal validity and inefficiency, as dis-
cussed below.
Ethics approval has been granted by the Human
Research Ethics Committee (HREC) of the University of
New South Wales and ratified by HRECs at the
University of Technology Sydney and Queensland
University of Technology.
Randomisation and blinding
Block randomisation of nursing homes will use a com-
puter generated allocation sequence and occur after ini-
tial consent. Randomisation will be stratified by
organisational affiliation to control for the influence of
organisational culture, policy and procedures on quality
of care. Randomisation will also be stratified by rurality
and dementia-specificity following evidence that these
variables may be associated with quality of care for resi-
dents with advanced dementia [18].
The pragmatic nature of the trial and complex nature
of the intervention requires careful consideration of the
feasibility versus desirability of blinding [43, 44]. The
statistician (GL) will be blinded to nursing home identity
for randomisation and analysis. However, nursing home
managers will not be blinded to allocation because they
need to make a fully informed decision regarding nurs-
ing home participation. Nursing staff and families at
nursing homes in the intervention arm will also know
that facilitated case conferencing is being implemented
because they will be participating. The design seeks to
limit potential for bias by omitting from participant in-
formation any reference to the study’s evaluative aims or
allocation of nursing homes to intervention versus usual
care arms. Instead, verbal and written information will
describe the study’s aim in more general terms as being
concerned with understanding the factors associated
with quality of care for residents with advanced demen-
tia by comparing between nursing homes with different
characteristics. Research assistants collecting process
and outcome data will also be blinded to the specific de-
sign and aims of the study, and each assistant will visit
nursing homes in either the intervention or usual care
arm only. However, the lead investigator (MA), the na-
tional project coordinator (TL), and two state-based pro-
ject managers will remain unblinded for the purpose of
liaising with implementation personnel and ensuring
protocol fidelity.
Sites
The study will be conducted in nursing homes in two
Australian capital cities (Sydney, New South Wales, and
Brisbane, Queensland). Nursing home inclusion criteria
are designed to ensure sufficient numbers of eligible res-
idents and are: 1) ≥100 beds, 2) ≥50 % residents with
dementia, and 3) designation as ‘high care’ (i.e. the most
intensive level of care provided by Australian nursing
homes). To minimise selection bias, nursing homes will
be identified from listings on an Australian government
website [45] and approached in random order.
Participants and recruitment
Residents will be eligible to participate if they have a
diagnosis of dementia documented in nursing home re-
cords and identified as having advanced disease as deter-
mined by: 1) a score on the Functional Assessment
Staging Tool (FAST) [46] in dementia of ≥6a that has
been stable for 1 month, and 2) a score on the Australia–
modified Karnofsky Performance Status (AKPS) [47] of
≤50 (i.e. a performance status of ‘considerable assistance
and frequent medical care required’ or worse). The FAST
was chosen because of its utility in the advanced stages of
dementia and its prognostic value; a FAST stage 7c com-
bined with functional dependency (measured here by the
AKPS) is predictive of an average survival of <6 months
[48]. Potentially eligible residents will be identified by
nursing home staff and screened by the project team.
Because residents will lack capacity to provide in-
formed consent, this will be sought on their behalf from
someone with designated authority as defined by legisla-
tion in New South Wales (‘person responsible’) and
Queensland (‘statutory health attorney’). For each par-
ticipating resident, written informed consent will be ob-
tained additionally from a family member who visits the
resident regularly and has authority to be involved in de-
cisions about the resident’s care. This person can be the
same or different to the person responsible/statutory
health attorney who gives consent for the resident to
participate.
Permanent nurses and care assistants who provide
care for enrolled nursing home residents will be invited
to participate via group emails and face-to-face staff
meetings. Community health professionals (e.g. GPs,
community nurses, allied health professionals) attending
case conferences for participating residents will be in-
vited to provide written informed consent to participate
in exit interviews and to allow case conferences to be
audio-recorded for content analysis.
Conditions
The intervention and usual care arms to be compared in
this study are as follows.
Intervention – facilitated case conferencing
The intervention utilises elements of two models for
bringing about change in organisational culture, namely
clinical leadership [49] and train-the-trainer [50]. A Pal-
liative Care Planning Coordinator (PCPC) will be
appointed at each nursing home and trained to work on
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the project in a funded capacity for 16 h (0.4 full time
equivalent) per week. Because change may be more sus-
tainable when led from within an organisation, PCPCs
will be appointed from existing nursing staff at interven-
tion nursing homes based on criteria relating to clinical
training and expertise (typically a senior registered
nurse), relationships with staff, and identification by
managers as a 'change champion' using established cri-
teria [51].
As part of their orientation to the role, PCPCs will at-
tend one week (35 h) of interactive training in which
they will be provided with materials and tuition on the
principles of person-centred palliative care for people
with dementia as well as the organisation, conduct and
documentation of case conferences and person-centred
care plans. Materials will be based on a previous re-
source developed by members of the team for case con-
ferencing in aged care more generally [39], recently
adapted to meet the specific needs of residents with ad-
vanced dementia and their families. In practical terms,
PCPCs will be trained to: 1) use evidence-based ‘triggers’
to identify residents with advanced dementia at a time-
point likely to benefit from a case conference (Table 1);
2) organise, set an agenda, facilitate and document case
conferences with optimal involvement from family,
multi-disciplinary nursing home staff and external health
professionals (e.g. GPs); 3) develop and oversee imple-
mentation of palliative care plans; and 4) train other
nursing home staff in person-centred palliative care.
Consistent with MRC guidance for complex interven-
tions [38], training will focus on how the intervention
might best be adapted to local conditions at each nurs-
ing home and integrated within existing initiatives.
Training will be run by a multidisciplinary team includ-
ing physicians, nurses and consumers. It will make use
of experiential learning as well as didactic approaches,
and illustrate key learning objectives with case studies.
Following training, PCPCs will be supported on an on-
going basis by means of bi-weekly teleconferences aimed
at building peer support and group learning via a com-
munity of practice [52], as well as individual telephone
support and site visits from the project team as required.
Usual care
In nursing homes, randomised to the usual care arm, no
education, training or support will be provided by the
study team, but neither will any restriction be placed on
service provider education or training where this is
current practice. The level, duration and type of service
provider initiatives will be documented so these can be
controlled for as potential confounders.
Data collection
Baseline data
Nursing home, staff, resident and family characteristics
Characteristics that have potential to influence outcomes
will be collected as per Table 2 via nursing home records
and staff/family report.
Process and sustainability data
Data will be collected as per Table 3 for use in analyses
aimed at measuring ‘dose’ of the intervention and de-
scribing facilitative or obstructive mechanisms that may
be used to inform future implementation [38]. Complex
interventions in nursing homes can be influenced by a
large range of variables at the levels of resident, family,
staff and nursing home. Capturing information about
these variables is important to enable understanding of
which groups the intervention may be optimal for, how
it might be adapted to meet the needs of other groups,
and the broader contexts in which it is likely to be more
or less successful.
Outcome data
Intervention and usual care arms will be compared on
the following outcomes collected at baseline and speci-
fied time-points.
Primary endpoint
Family-rated EOL outcomes will be measured using the
End of Life in Dementia (EOLD) Scales [53]. These
scales have established internal consistency (Cronbach’s
alpha = 0.68–0.83) and convergent validity in the nursing
home setting [54], and have been rated the best mea-
sures for evaluating dementia-specific palliative care in
nursing homes [55]. EOLD data from the CASCADE
Study (Choices, Attitudes, and Strategies for Care of Ad-
vanced Dementia at the End of life) will enable compari-
son with US residents [56]. The EOLD Scales will be
used to measure: a) symptom-related comfort during the
Table 1 Triggers prompting the organisation and conduct of a
case conference
• Admission to the nursing home
• Return to the nursing home following discharge from acute
hospital
• Increase in falls
• Change in clinical status
• New/worsening symptoms
• Poor appetite or skin integrity
• Annual management plan review
• Receipt of a complaint
• Family disagreement about care
• Family distress
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Table 2 Data collected on characteristics of facilities, residents, families and staff with potential to influence outcomes
Level Time point(s) Variables/measures
Facility Baseline Number of beds; high care versus low care; private versus not-for-profit status; organisational affiliation; dementia-specific
status; accommodation and amenities; management structure; person-centredness (PCECAT)
Baseline and 3
monthly
Number of new admissions and deaths; number and proportion of residents with dementia and advanced dementia;
proportion of residents requiring complex care
Involvement of GPs and other community services; rates of acute care episodes and length of stay (including ED
presentations with admission and actual admission); rates of potentially non-palliative interventions* and intra-venous
anti-biotics
Staff profile and turnover (resignations and new staff); resident to staff ratio; use of agency staff; staff training
Accidents/incidents
Resident Baseline Age; gender; previous occupation; years of education
Time since dementia diagnosis; BMI
Length of stay in NH
Baseline and 3
monthly
Dementia stage (FAST); performance statues (AKPS); support needed for activities of daily living (BANS); comorbidities
and level of care needs (ACFI); food and fluid intake; palliative care phase (PCOC phase)
Number of visitors and frequency of visits
Whole time on
study
ED visits and hospitalisations (reason, whether a GP was consulted in decision to hospitalise, length of stay);
potentially non-palliative interventions*; goals of care; reports for any RMMRs conducted
Last month of life Place of death and(if not NH) reason for transfer and who decided; symptoms; formal symptom assessments;
management over last 24 h of life (detailed); non-pharmacological management; input from health professionals;
medication changes and rationale
Family Baseline Self-reported relationship to resident; age; gender; education; occupation; dependents; frequency/duration of visits;
person responsible status** and prior involvement in decision-making




Knowledge and attitudes towards advanced dementia (qPAD)
ACFI = Aged Care Funding Instrument [78]; AKPS = Australia–modified Karnofsky Performance Status [47]; BANS = Bedford Alzheimer Nursing Severity (BANS) [79];
BMI = body mass index; ED = emergency department; FAST = Functional Assessment Staging of Alzheimer’s Disease [46]; GP = general practitioner; NH = nursing
home; PCECAT = Person Centred Environment and Care Assessment Tool [80]; PCOC= Palliative Care Outcomes Collaborative [81]; qPAD= questionnaire on Palliative
care for Advanced Dementia [64]; RMMR = residential medication management review; * potentially non-palliative interventions defined as ventilation, resuscitation,
nasogastric/ percutaneous endoscopic gastrostomy (PEG) feeding, cardiopulmonary resuscitation, dialysis, oxygen, transfusion; **person responsible status concerns a
person’s legal status as a surrogate decision-maker
Table 3 Variables collected to measure ‘dose’ of facilitated case conferencing and scoring system used
Facility level dose Scoring
1. Extent to which PCPC able to work 2 days per week 0 for lesser extent, 1 for moderate extent, 2
for large extent
2. PCPC role diffused through RACF beyond PCPC 0 for lesser extent, 1 for moderate extent, 2
for large extent
3. PCPC reported manager to be supportive 0 for lesser extent, 1 for moderate extent, 2
for large extent
4. Evaluation by project team regarding extent that PCPCs were able to fulfil expectations and
roles according to training/handbook
0 for lesser extent, 1 for moderate extent, 2
for large extent
Resident level dose
1. Number of case conferences 0 for none, 1 for one, 2 for two, 3 for three
more
2. Median number of professional carer disciplines other than RN and GP involved 0 for none, 1 for one, 2 for two, 3 for three
or more
3. One or more case conference(s) attended by a GP? 0 for no, 1 for yes
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last 7 days of life (Comfort Assessment in Dying with
Dementia; CAD–EOLD), including physical distress,
dying symptoms, emotional distress and wellbeing; b)
symptom management in the last 90 days of life (Symp-
tom Management at the End of life in Dementia; SM–
EOLD); and c) family satisfaction with care during the last
90 days of life (Satisfaction with Care at the End of life in
Dementia; SWC–EOLD). Whilst the CAD-EOLD and
SM-EOLD have been validated for rating either by family
or nurses, family ratings will be the primary endpoint be-
cause family perceptions of EOL suffering and its manage-
ment are important outcomes for palliative care in and of
their own right and family ratings may be less subject to
response bias than those of nurses who are delivering care
as well as reporting on its quality. All scales will be rated
by families 4 to 6 weeks following resident death to avoid
rating during the initial period of acute grief [57].
Secondary endpoints
a. Nurse-rated symptom-related comfort and symptom
management will be measured using the CAD-EOLD
and SM-EOLD Scales and rated 4 weeks following
residents’ death by the nurse who provides most care
in the last 7 days and 90 days of life respectively.
Nurse proxy ratings will be included because they
offer a 24-h observational perspective that comple-
ments family proxy ratings [58].
b. Proxy nurse-rated resident QOL will be measured
second weekly using the Quality of Life in Late-stage
Dementia (QUALID) Scale [59]. This 11-item instru-
ment is the only advanced dementia-specific QOL
measure and has been specifically designed for proxy
rating. It has shown convergent validity, internal
consistency (Cronbach’s alpha = 0.77) and test-retest
(ICC = 0.81) and inter-rater (k = 0.83) reliability.
QUALID data from the Caring for Aged Dementia
Care Resident Study (CADRES) [60] and CASCADE
[56] will enable comparison with large Australian
and US samples. For the purposes of economic
evaluation, QOL will also be assessed by proxy using
the EQ-5D-5 L [61], a five level version of the
world’s most widely used multi-attribute utility in-
strument EQ-5D [62] which has been revised to in-
clude a larger number of severity levels among its
response options (therefore giving greater sensitiv-
ity). The EQ-5D has been widely used in dementia
studies [63].
c. A palliative approach to care at the nursing home
level will be measured using the following indices:
rates of potentially inappropriate non-palliative inter-
ventions and acute care episodes and length of stay
(including ED presentations with admission and ac-
tual admission); rates of inappropriate acute care
episodes and inappropriate non-palliative interven-
tions as judged again by an expert review of 10 % of
admissions at each nursing home; and number/type
of complaints from families regarding the quality of
care. Potentially non-palliative interventions will be
defined as ventilation, resuscitation, nasogastric/per-
cutaneous endoscopic gastrostomy (PEG) feeding,
intravenous antibiotics and fluids, dialysis, transfu-
sion, oxygen and surgery. Adverse events will be de-
fined as falls with/without injury, skin tears, injuries
during care, and medication incidents. Source docu-
ments will include nursing records, transfer letters,
discharge summaries and medical records written on
admission and discharge. Where records are not
kept, data will be based on report by managers. The
10 % of admissions for expert review will comprise a
random sample of admissions over the previous year,
focusing on residents with dementia.
d. Nursing home staff ’s attitudes to, knowledge of and
confidence in providing palliative/EOL care to
residents with advanced dementia will be evaluated
using the questionnaire on Palliative Care for
Advanced Dementia (qPAD) [64]. This 35-item scale
has demonstrated satisfactory factor structure and
internal consistency (Cronbach’s alpha 0.58–0.90).
The qPAD will be administered before and after
training to PCPCs and at baseline and 3-monthly in-
tervals to participating nursing staff.
Endpoints for economic evaluation
The economic evaluation of this trial will take a cost-
utility approach, in which health benefit will be esti-
mated in terms of quality adjusted life years (QALYs)
gained. This will capture expected intervention effects
on morbidity within the context of any unexpected
change in survival. Resident QOL will be estimated
using nurse-ratings on the EQ-5D-5 L introduced above,
for which Australian population preference weights have
been valued by a representative sample of the general
population [65]. Healthcare costs will be collected from
the health care and societal perspectives. Program costs
will include training costs (materials, trainer’s time and
opportunity cost of trainee time); and case conference
costs (session time, travel time and distance travelled by
attendees). Health service use during the study period
will be extracted from nursing home records, to includ-
ing medical service utilisation (such as medical practi-
tioner visits and hospital admissions, procedures
performed and pharmaceutical drug usage. Total health
service costs will be derived by multiplying the units of
resource used by the relevant factor: the Australian
Government’s Medicare Schedule Benefit item fee,
Pharmaceutical Benefits Scheme price, or the Australian
Refined Diagnosis-Related Group cost.
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Qualitative sub-study
A qualitative sub-study will seek to inform in-depth un-
derstanding of the processes necessary for implementing
case conferencing and the intervention’s acceptability to
families, nursing home staff and other participating
health professionals. We will also be interested to learn
about other factors influencing the quality of EOL de-
mentia care that case conferencing may interact with.
Data will be collected via semi-structured interviews
conducted at the end of the project with all PCPCs and
a random sample of families, nursing home staff and
community health professionals caring for enrolled resi-
dents in each arm. Semi-structured interviews in both
arms will explore perceptions of factors perceived to in-
fluence quality of EOL care for residents with advanced
dementia. In the intervention arm, interviews will also
explore perceptions of the usefulness and facilitators/
barriers to implementing case conferencing for people
with advanced dementia. PCPCs will also be asked what
advice they would give to someone else taking on the
role of PCPC and to describe any plans for continuing




There will be two considerations for sample size in this
cluster randomised trial, the number of clusters (nursing
homes) and number of participants per cluster. In the
absence of established minimal clinically important dif-
ferences on the EOLD Scales, we follow a common rule-
of-thumb for patient reported outcomes and assume 0.5
standard deviation (SD) [66]. Sample size is based on the
EOLD scale with the highest intra-cluster correlation
(ICC) (i.e., requiring the greatest number of clusters),
namely the CAD-EOLD. To detect a change in CAD-
EOLD of half a standard deviation (i.e. a change in score
of at least 3), with a two-sided 5 % significance level,
power of 80 % and an intracluster correlation coefficient
of 0.05 (estimated from unpublished data sourced from
Dutch nursing homes), a sample size of 8 clusters per
group (16 in total) with 15 residents per cluster will be
necessary. Given an anticipated dropout rate at the resi-
dent level of 10 %, a recruitment sample of 272 residents
(17 per site) will be needed for a final sample of 240 resi-
dents. We will also over-sample nursing homes by two
in each arm (i.e. 10 in each arm, 20 in total) to protect
against drop-out by managers. An interim check will be
conducted on blinded data at 6 months to assess
whether these assumptions require adjustment and
whether re-estimation of sample size may be necessary.
The feasibility of enrolling 17 residents with advanced
dementia per nursing home with a life expectancy of less
than the study period (<18 months) is based on: 1) a
review of death data at one large (>200 beds) metropol-
itan Sydney nursing home, and 2) research showing that
40 % of people admitted to nursing homes with ad-
vanced dementia die within 1 year, and 3) resident par-
ticipants’ eligibility criteria will likely further decrease
participant life expectancy [48, 67].
Analysis
Aim 1 – Efficacy Primary and secondary analyses will
be performed on an intention to treat (ITT) basis. De-
scriptive statistics will be used to compare characteristics
at individual and nursing home-levels in each group at
baseline, accounting for the clustering effect in the
former.
Mixed or ‘multilevel’ modelling will be used to deter-
mine the effects of case conferencing and usual care on
primary and individual-level secondary outcomes. Mixed
models will allow adjustment for both individual (i.e.
resident, family or staff ) and cluster-level covariates as
well as adjustment for the inherent correlation within
clusters.
Cluster level analyses will be implemented to deter-
mine the effect of the intervention on nursing home-
level outcomes. Analyses will be weighted by cluster size
as required. Results will be interpreted and generalised
accordingly.
Aim 2 – Process and sustainability
Following ITT analyses, further analyses will be con-
ducted that control for the ‘dose’ of intervention re-
ceived by each nursing home and resident based on
variables and scoring outlined in Table 3.
Further understanding of processes and sustainability
will be informed by qualitative analysis of interview data,
which will use a thematic framework approach [68] that
is both deductive (i.e. a ‘top-down’ approach informed
by the aims of the research and the structure of the
interview topic guide) and inductive (i.e. a ‘bottom up’
approach grounded in the responses of the participants).
Analysis will be conducted by two independent re-
searchers using a constant comparative method [69],
with any differences in coding resolved by discussion.
Aim 3 - Economic evaluation
For the cost-effectiveness component, the benefit of case
conferencing relative to usual care will be calculated in
terms of the incremental QALYs gained. The cost of the
intervention will be measured along with any cost-savings
due to avoided healthcare utilisation. Results will be pre-
sented in terms of the incremental cost-effectiveness ratio
(ICER). Many of these model parameters will not be pow-
ered for statistical significance. Therefore, mean estimates
of resource utilisation will be used and confidence
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intervals will be generated by boot-strapping the data.
Sensitivity analyses will be undertaken to explore the ro-
bustness and validity of the cost-effectiveness data and to
test any assumptions used in the economic model.
Discussion
The cluster randomised trial of palliative care case con-
ferencing described in this article will make an import-
ant contribution to the evidence base concerned with
family case conferencing for residents with advanced de-
mentia who are dying in nursing homes. As well as be-
ing the first to test efficacy and cost-effectiveness, the
trial includes measures and analyses of process that will
inform understanding of factors influencing implementa-
tion of this complex intervention at the levels of nursing
home, staff, resident and family.
The study’s design, methods and intervention have
been informed by the team’s experience in previous
RCTs and other studies of case conferencing and de-
mentia care [31, 34, 35, 70–74]. The study builds on this
previous work by: 1) adapting facilitated approaches to
case conferencing found efficacious for people with ad-
vanced cancer in the community [31, 34, 35]; 2) using
evidence-based approaches to teaching person-centred
dementia care to nursing home staff [60, 70, 73, 74]; and
3) empowering nursing home staff to bring about change
within their own nursing homes by means of clinical
leadership, resources and ongoing support [72].
The intervention is aligned with Australian [75] and
international [76] policy directions regarding the key ele-
ments thought to mediate high quality person-centred
dementia and palliative care. It has also been designed
specifically to address challenges in the Australian nurs-
ing home context relating to variations in workforce
profiles, high staff turnover, poor continuity of care, and
large numbers of unregulated and untrained personal
care workers [77]. It is important that interventions align
with business and funding models to maximise potential
for sustainable translation into practice and impact on
health outcomes that matter to all stakeholders involved.
To ensure the study findings are relevant to practice, the
resident population will be identified for inclusion using
tools currently available for use in clinical practice [46, 47]
and associated with the stage of dementia where facilitated
case conferencing is hypothesised to have most impact.
Where appropriate, opportunities have also been taken to
ensure comparability between data collected in this re-
search and the world’s largest study of nursing home care
for residents with advanced dementia, the US CASCADE
study [56].
The strengths of the IDEAL Project lie in its prag-
matic nature [43, 44], which is expected to enhance
external validity and inform understanding of effect-
iveness, implementation, and cost-effectiveness to
inform future development and adaptation. On the
downside, the proposed design and intervention will
enable only partial blinding, and there is likely to be
heterogeneity among nursing homes and residents in
each arm, limiting internal validity. Collection of de-
tailed information about process is intended to ensure
that findings from this research are informative to
practice and policy regardless of whether evidence is
found for an overall effect on the primary endpoint.
As well as disseminating these findings via publica-
tions and conference presentations, the researchers
expect to produce dementia-specific resources for fa-
cilitated case conferencing that will be made available
online so they can be kept up to date and accessed
freely by the nursing home sector.
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